Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Neurobiology of Disease
|
June 2, 2005
Role of caspase-3 in ethanol-induced developmental neurodegeneration
Chainllie Young, Kevin A Roth, Barbara J Klocke, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2017
A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjects
Kaushik Ghosal, Michael Haag, Philip B Verghese, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2012
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis
Joseph M Castellano, Rashid Deane, Andrew J Gottesdiener, et al.
Journal of Personalized Medicine
|
October 28, 2025
Implementation of an Alzheimer's Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study
Mark Monane, Robert M Carlile, Kim G Johnson, et al.
Diagnostics (Basel, Switzerland)
|
August 29, 2024
PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology
Stephanie M Eastwood, Matthew R Meyer, Kristopher M Kirmess, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 5, 2005
Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain
James W Maas, Ricardo A Indacochea, Lisa M Muglia, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 2, 2024
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer's Disease
Douglas Galasko, Martin R Farlow, Brendan P Lucey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 17, 2026
Plasma p-tau217 predicts PET-based pathological staging for precision Alzheimer disease assessment
Han-Kyeol Kim, Jae Hoon Lee, Joong-Hyun Chun, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 20, 2021
The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis
Kristopher M Kirmess, Matthew R Meyer, Mary S Holubasch, et al.
JAMA
|
July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Neurobiology of Disease
|
June 2, 2005
Role of caspase-3 in ethanol-induced developmental neurodegeneration
Chainllie Young, Kevin A Roth, Barbara J Klocke, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2017
A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjects
Kaushik Ghosal, Michael Haag, Philip B Verghese, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2012
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis
Joseph M Castellano, Rashid Deane, Andrew J Gottesdiener, et al.
Journal of Personalized Medicine
|
October 28, 2025
Implementation of an Alzheimer's Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study
Mark Monane, Robert M Carlile, Kim G Johnson, et al.
Diagnostics (Basel, Switzerland)
|
August 29, 2024
PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology
Stephanie M Eastwood, Matthew R Meyer, Kristopher M Kirmess, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 5, 2005
Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain
James W Maas, Ricardo A Indacochea, Lisa M Muglia, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 2, 2024
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer's Disease
Douglas Galasko, Martin R Farlow, Brendan P Lucey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 17, 2026
Plasma p-tau217 predicts PET-based pathological staging for precision Alzheimer disease assessment
Han-Kyeol Kim, Jae Hoon Lee, Joong-Hyun Chun, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 20, 2021
The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis
Kristopher M Kirmess, Matthew R Meyer, Mary S Holubasch, et al.
JAMA
|
July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
Page
of 5